Sung-Kwon Lee

Dr. Sung-Kwon Lee

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
SLSung-Kwon Lee
Sung-Kwon Lee
HKHong Rip Kim
Hong Rip Kim
YJYing-Yu Jin
Ying-Yu Jin
Seung Hwan YangSeung Hwan Yang
Seung Hwan Yang
JSJoo-Won Suh
Joo-Won Suh

Verified
Journal Article
Open access
PDF file
Hae Lim KimHae Lim Kim
Hae Lim Kim
SLSung-Kwon Lee
Sung-Kwon Lee
DMDa-Eun Min
Da-Eun Min
TBTonking Bastola
Tonking Bastola
BCBo Yoon Chang
Bo Yoon Chang
DLDong-Ryung Lee
Dong-Ryung Lee
Alzheimer’s disease (AD) is a worldwide problem. Currently, there are no effective drugs for AD treatment. Scrophularia buergeriana Miquel (SB) is a traditional herbal medicine used in Korea to treat various diseases. Our previous studies have shown that ethanol extract of SB roots (SBE, Brainon®) exhibits potent anti-amnesic effects in Aβ1–42- or scopolamine-treated memory impairment mice model and neuroprotective effects in a glutamate-induced SH-SY5Y cell model. In this study, we evaluated the therapeutic effects of Brainon® and its mechanism of action in senescence-accelerated mouse prone 8 (SAMP8) mice. Brainon® (30 or 100 mg/kg/day) was orally treated to six-month-old SAMP8 mice for 12 weeks. Results revealed that Brainon® administration effectually ameliorated cognitive deficits in Y-maze and passive avoidance tests. Following the completion of behavioral testing, western blotting was performed using the cerebral cortex. Results revealed that Brainon® suppressed Aβ1–42 accumulation, Tau hyperphosphorylation, oxidative stress, and inflammation and alleviated apoptosis in SAMP8 mice. Brainon® also promoted synaptic function by downregulating the expression of AChE and upregulating the expression of p-CREB/CREB and BDNF. Furthermore, Brainon® restored SAMP8-reduced expression of ChAT and -dephosphorylated of ERK and also decreased AChE expression in the hippocampus. Furthermore, Brainon® alleviated AD progression by promoting mitophagy/autophagy to maintain normal cellular function as a novel finding of this study. Our data suggest that Brainon® can remarkably improve cognitive deficiency with the potential to be utilized in functional food for improving brain health.

28 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Hae Lim KimHae Lim Kim
Hae Lim Kim
SLSung-Kwon Lee
Sung-Kwon Lee
DMDa-Eun Min
Da-Eun Min
BCBong-Keun Choi
Bong-Keun Choi
DLDong-Ryung Lee
Dong-Ryung Lee
Since the potential of (3:1) mixtures of Atractylodes macrocephala and Amomum villosum extracts has been proposed in the management of obesity, the purpose of present study was to investigate the effects of AME:AVE (3:1) mixture on weight loss, obesity-related biochemical parameters, adipogenesis and lipogenesis related proteins in 3T3-L1 cells and HFD-induced obesity in a mouse model. Treatment with AME:AVE (3:1) mixture inhibited lipid accumulation. Furthermore, the treatment with 75 and 150 mg/kg of AME:AVE (3:1) significantly decreased the body weight gain, white adipose tissue (WAT) weight, and plasma glucose level in HFD-induced obese mice. Moreover, treatment with 75 and 150 mg/kg AME:AVE (3:1) also significantly lowered the size of adipocytes in adipose tissue and reduced the lipid accumulation in liver. AME:AVE (3:1) treatment significantly decreased the expression of proteins related to adipogenesis and lipogenesis in 3T3-L1 adipocytes and WAT of HFD-induced obese mice. These results suggest that the AME:AVE herbal mixture (3:1) has anti-obesity effects, which may be elicited by regulating the expression of adipogenesis and lipogenesis-related proteins in adipocytes and WAT in HFD-induced obesity in mice.

Verified
Journal Article
Open access
PDF file
HLHaejin Lee
Haejin Lee
SLSo Jung Lee
So Jung Lee
SLSung-Kwon Lee
Sung-Kwon Lee
BCBong-Keun Choi
Bong-Keun Choi
DLDong-Ryung Lee
Dong-Ryung Lee
Periodontitis, a disease caused by inflammation of oral bacteria, contributes to the loss of alveolar bone and destruction of connective tissues. Porphyromonas gingivalis, a Gram-negative bacterium, is known to possess important pathogenic factors for periodontal disease. In this study, we investigated the anti-periodontitis effects of Magnolia kobus extract (MKE) and magnolin as a component of Magnolia kobus (MK) in murine macrophage RAW 264.7 cells stimulated with Porphyromonas gingivalis lipopolysaccharide (LPS). Effects of MKE and magnolin on the mechanism of RAW 264.7 cellular inflammation were determined by analyzing nitric oxide (NO) production and Western blot protein expression (n = 3). MKE/magnolin inhibited NO production without affecting cell survival. MKE/magnolin treatment inhibited LPS-induced pro-inflammatory cytokines, expression levels of matrix metalloproteinases (MMPs such as MMP-1, 3, 8, 9, and 13), and protein levels of inflammatory mediators (such as TNF-α, IL-1β, and mPGES-1). MKE/magnolin also suppressed NF-κB activation by inhibiting the TLR4 signaling pathway. These findings suggest that MKE has a therapeutic effect on inflammatory periodontal disease caused by oral bacterium P. gingivalis and that magnolin is a major functional component in the anti-inflammatory effect of MKE.

14 May 2024 in Phytotherapy Research
Verified
Journal Article
Closed access
SLSung-Kwon Lee
Sung-Kwon Lee
DLDong-Ryung Lee
Dong-Ryung Lee
Hae Lim KimHae Lim Kim
Hae Lim Kim
BCBong-Keun Choi
Bong-Keun Choi
KKKang‐Beom Kwon
Kang‐Beom Kwon

20 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Hae Lim KimHae Lim Kim
Hae Lim Kim
SLSung-Kwon Lee
Sung-Kwon Lee
DMDa-Eun Min
Da-Eun Min
BCBong-Keun Choi
Bong-Keun Choi
DLDong-Ryung Lee
Dong-Ryung Lee
Dyglomera® is an aqueous ethanol extract of the fruit pods of Dichrostachys glomerata, a Cameroonian spice. Several studies have shown its anti-diabetic and anti-obesity effects. However, the underlying mechanisms for such effects remain unclear. Thus, the objective of this study was to investigate the anti-obesity effect of Dyglomera® and its underlying mechanisms in mice with high-fat diet-induced obesity and 3T3-L1 adipocytes. Our results revealed that Dyglomera® inhibited adipogenesis and lipogenesis by regulating AMPK phosphorylation in white adipose tissues (WATs) and 3T3-L1 adipocytes and promoted lipolysis by increasing the expression of lipolysis-related proteins. These results suggest that Dyglomera® can be used as an effective dietary supplement for treating obesity due to its modulating effect on adipogenesis/lipogenesis and lipolysis.